EFFECTS OF ELUXADOLINE TREATMENT ON ABDOMINAL AND BOWEL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA REPORTING INADEQUATE SYMPTOM CONTROL WITH LOPERAMIDE: AGGREGATED RESULTS FROM PHASE 3 AND 4 CLINICAL TRIALS

Darren M Brenner  1     Gregory Sayuk  2     Mazen Saeed  3     Peter Janiszewski  4     Louis Liu  5    
1 Northwestern University, Chicago, United States
2 Washington University School of Medicine, St. Louis, United States
3 AbbVie Inc, Madison, United States
4 AbbVie Inc, Toronto, Canada
5 University Health Network, Toronto, Canada

Topic
Disease Mechanisms, Gut Microbiota, Neurogastroenterology & Motility, Paediatrics

Session
IBS I

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing